Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Clinical Trials
Collaboration
Funding
Research and Development
AnchorDx enrolling U.S. clinical trial for bladder cancer assay
The study, which will enroll more than 1,000 participants, aims to evaluate the noninvasive, qPCR assay which detects two DNA methylation biomarkers in urine specimens from patients suspected of having bladder cancer.
November 23, 2022
Biological Dynamics embarks on clinical utility studies for pancreatic cancer detection assay
Biological Dynamics said that it is collaborating with Qure Healthcare and Curta to also evaluate the effects of its pancreatic cancer detection assay on patient outcomes and healthcare economics.
November 23, 2022
Biocare Medical acquires Empire Genomics to expand molecular biomarker portfolio
The acquisition of Empire Genomics will expand Biocare Medical’s molecular biomarker portfolio substantially.
November 22, 2022
Qiagen adds monkeypox test to automated PCR platform
Addressing a need to improve surveillance of monkeypox, Qiagen announced that it has launched a research-use-only monkeypox test strip capable of detecting both variants of the virus.
November 22, 2022
PerkinElmer launches adeno-associated virus vector detection kits for research
The new kits use bead-based luminescent amplification to provide researchers with an option that is less time-consuming than ELISA and other wash-based tests, as well as having a wide detection range and high throughput.
November 21, 2022
Lancet report on gaps in European cancer research calls for prioritization of prevention, early diagnosis
A report published in Lancet Oncology found that an estimated 100 million cancer screening tests were missed during the first year of the COVID-19 pandemic.
November 16, 2022
Most Popular
DNA forensic evidence frees Ohio man of rape, attempted rape
Low-value prostate cancer screening has Medicare spending ramifications, study finds
‘Good’ cholesterol worse for some adults: NIH study
Empatica receives FDA clearance for digital biomarker platform, closes Series B financing
PerkinElmer launches adeno-associated virus vector detection kits for research
Widespread HbA1c screening enables earlier type 2 diabetes diagnosis in U.K. study
BARDA to support algorithm and app development for infectious disease detection
Support for algorithm and app development is part of BARDA’s new Digital Medical Countermeasures program aimed at developing digital tools to enable faster, more accessible approaches during public health emergencies.
November 9, 2022
Roche points to results of heart failure study leveraging its cardiac hormone biomarker and test
The results were shared this week at an American Heart Association Late-Breaking Scientific Session and published simultaneously in the Lancet.
November 9, 2022
Bio-Rad Laboratories, NuProbe USA sign licensing agreement for digital PCR assays
The agreement allows NuProbe to license its allele enrichment technologies to Bio-Rad for the development of multiplexed digital PCR assays
November 8, 2022
Nucleai to present data on multiplex immunofluorescence analysis for colorectal cancer research
Nucleai will present data this week demonstrating the capability of multiplex immunofluorescence analysis to correlate spatial features with patient outcomes in colorectal cancer.
November 7, 2022
Mayo Clinic, Numares Health expand collaboration, develop AI-enabled diagnostic testing for chronic disease
Expanding upon Mayo Clinic’s clinical research support for Numares Health, the collaboration will focus on researching and developing AI-enabled diagnostic testing solutions.
November 3, 2022
Precision for Medicine announces NGS-driven improvement in cancer mutation identification
In a collaboration with Thermo Fisher, Precision for Medicine scanned tumors using Thermo’s Oncomine Precision Assay FX to uncover the genomic profiles of tumors within Precision’s biospecimen library.
November 3, 2022
Page 1 of 26
Next Page
